In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosa
Authors:
- Dawrin Pech-PuchDPDawrin Pech-Puch
- Mar Pérez-PovedanoMPMar Pérez-Povedano
- Marta Martinez-GuitianMarta Martinez-Guitian
- Cristina Lasarte-MonterrubioCLCristina Lasarte-Monterrubio
- Juan Carlos Vázquez-UchaJuan Carlos Vázquez-Ucha
- Germán BouGBGermán Bou
- Jaime RodríguezJaime Rodríguez
- Alejandro BeceiroABAlejandro Beceiro
- Carlos JimenezCarlos Jimenez
Open Access
- 23 June 2020
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 18 (6) , 326
Abstract
The pyrrole-imidazoles, a group of alkaloids commonly found in marine sponges belonging to the genus Agelas, display a wide range of biological activities. Herein, we report the first chemical study of the secondary metabolites of the sponge A. dilatata from the coastal area of the Yucatan Peninsula (Mexico). In this study, we isolated eight known alkaloids from an organic extract of the sponge. We used NMR and MS analysis and comparison with existing databases to characterize the alkaloids: ageliferin (1), bromoageliferin (2), dibromoageliferin (3), sceptrin (4), nakamuric acid (5), 4-bromo-1H-pyrrole-2-carboxylic acid (6), 4,5-dibromopyrrole-2-carboxylic acid (7) and 3,7-dimethylisoguanine (8). We also evaluated, for the first time, the activity of these alkaloids against the most problematic multidrug-resistant (MDR) pathogens, i.e., the Gram-negative bacteria Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii. Bromoageliferin (2) displayed significant activity against P. aeruginosa. Comparison of the antibacterial activity of ageliferins 1–3 (of similar structure) against P. aeruginosa revealed some relationship between structure and activity. Furthermore, in in vitro assays, 2 inhibited growth and biofilm production in clinical strains of P. aeruginosa. Moreover, 2 increased the survival time in an in vivo Galleria mellonella model of infection. The findings confirm bromoageliferin (2) as a potential lead for designing new antibacterial drugs.Keywords
Funding Information
- State Agency for Research (AEI) of Spain (RTI2018-093634-B-C22)
- BLUEBIOLAB (0474_BLUEBIOLAB_1_E), Programme INTERREG V A of Spain-Portugal (POCTEP). (0474_BLUEBIOLAB_1_E)
- pFIS program (FI18/00315)
This publication has 65 references indexed in Scilit:
- Antimicrobial Resistance: Implications and CostsInfection and Drug Resistance, 2019
- Marine Natural Products in Medicinal ChemistryACS Medicinal Chemistry Letters, 2018
- Bioactive Secondary Metabolites from the Marine Sponge Genus AgelasMarine Drugs, 2017
- Chemistry and Biology of the Pyrrole–Imidazole Alkaloids2017
- Natural Products as Sources of New Drugs from 1981 to 2014Journal of Natural Products, 2016
- Marine Bromopyrrole Alkaloids: Synthesis and Diverse Medicinal ApplicationsCurrent Topics in Medicinal Chemistry, 2013
- Sequencing of superbugs seen as key to combating their spreadNature Medicine, 2010
- A Submarine Journey: The Pyrrole-Imidazole AlkaloidsMarine Drugs, 2009
- Biofilms: Survival Mechanisms of Clinically Relevant MicroorganismsClinical Microbiology Reviews, 2002
- Structure of dibromophakellin, a new bromine-containing alkaloid from the marine sponge Phakellia flabellataJournal of the Chemical Society D: Chemical Communications, 1971